Today: 21 July 2026
Browse Category

Sensex 27 September 2025 - 18 November 2025

Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Indian Stock Market Today, 18 November 2025: Sensex, Nifty Break Winning Streak as New-Age IPOs Steal the Show

The Indian stock market paused for breath on Tuesday, 18 November 2025, as benchmark indices snapped a six-session winning streak amid a global tech-led sell-off and profit booking in key heavyweights. At the same time, Dalal Street’s obsession with new-age listings – PhysicsWallah, Emmvee Photovoltaic and Capillary Technologies – stayed front and centre.
18 November 2025
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Sensex, Nifty Close Flat on Nov 13, 2025; Bank Nifty Hits Record High, Asian Paints Jumps; Rupee Near 88.66 as CPI Prints Record Low

Mumbai | Thursday, November 13, 2025 — Indian equities ended virtually unchanged on Thursday as investors booked profits after a three‑day rally and turned cautious ahead of Friday’s Bihar election results. The Sensex settled at 84,478.67 and the Nifty 50 at 25,879.15. Intraday, the Sensex briefly topped 84,919 and the Nifty reclaimed 26,010 before late selling pared gains. Metals and realty outperformed while IT and PSU banks lagged. Market breadth was negative with mid- and small-caps slipping about 0.3%. Reuters+2mint+2
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Key Facts: Indian equity benchmarks slumped sharply last week. The BSE Sensex gave up roughly 2,587 points and the Nifty 50 fell about 672 points over six trading days upstox.com livemint.com. This was the worst weekly decline in nearly six months, erasing about 90% of the recent rally from early September upstox.com livemint.com. Markets were roiled by external shocks: U.S. President Trump announced 100% tariffs on imported branded/pharma products and hiked H-1B visa fees to $100,000 per worker. These policy moves hit India’s tech and pharma stocks hard. Sectorally, IT was the biggest laggard and Pharma also plunged upstox.com livemint.com. Mid- and small-cap indices underperformed as well. In all, about ₹16 lakh crore of market capitalization was wiped out upstox.com upstox.com.
27 September 2025
1 3 4 5
Go toTop